VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $224,000 | -20.0% | 9,142 | -14.0% | 0.20% | -8.4% |
| Q1 2016 | $280,000 | -85.9% | 10,628 | -45.7% | 0.21% | -86.2% |
| Q4 2015 | $1,989,000 | +78.2% | 19,569 | +212.7% | 1.56% | +50.2% |
| Q3 2015 | $1,116,000 | +32.4% | 6,258 | +64.9% | 1.04% | +34.9% |
| Q2 2015 | $843,000 | +115.6% | 3,794 | +92.5% | 0.77% | +141.5% |
| Q1 2015 | $391,000 | +77.7% | 1,971 | +28.2% | 0.32% | +71.9% |
| Q4 2014 | $220,000 | – | 1,537 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |